We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

328 hedge funds and large institutions have $5.19B invested in Amedisys in 2022 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 127 increasing their positions, 91 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

40% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 91

14% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 56

10% more capital invested

Capital invested by funds: $4.72B → $5.19B (+$473M)

3.11% more ownership

Funds ownership: 89.76%92.87% (+3.1%)

1% more funds holding

Funds holding: 324328 (+4)

8% more call options, than puts

Call options by funds: $57.2M | Put options by funds: $52.8M

Holders
328
Holders Change
+4
Holders Change %
+1.23%
% of All Funds
5.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
64
Increased
127
Reduced
91
Closed
56
Calls
$57.2M
Puts
$52.8M
Net Calls
+$4.4M
Net Calls Change
-$6.63M
Name Holding Trade Value Shares
Change
Change in
Stake
State of New Jersey Common Pension Fund D
101
State of New Jersey Common Pension Fund D
New Jersey
$3.51M
SGH
102
Sivik Global Healthcare
Connecticut
$3.45M +$2.99M +20,000 New
BCC
103
Bridge City Capital
Oregon
$3.3M -$13.4K -90 -0.5%
Ohio Public Employees Retirement System (OPERS)
104
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.18M -$103K -692 -4%
CAM
105
Cresset Asset Management
Illinois
$3.07M -$35.3K -236 -1%
PNAA
106
Pictet North America Advisors
Switzerland
$3.06M -$319K -2,138 -11%
Simplex Trading
107
Simplex Trading
Illinois
$3.02M +$2.62M +17,507 New
YCM
108
Yousif Capital Management
Michigan
$2.98M +$50K +335 +2%
BNP Paribas Financial Markets
109
BNP Paribas Financial Markets
France
$2.97M -$6.31M -42,203 -71%
Credit Agricole
110
Credit Agricole
France
$2.86M
PCM
111
Portolan Capital Management
Massachusetts
$2.86M +$2.48M +16,607 New
MA
112
Montag & Associates
Georgia
$2.86M +$2.48M +16,591 New
GAM
113
Gotham Asset Management
New York
$2.7M +$675K +4,516 +40%
ERSOT
114
Employees Retirement System of Texas
Texas
$2.67M
AIP
115
Ameritas Investment Partners
Nebraska
$2.66M
KWILP
116
Kiwi Wealth Investments Limited Partnership
New Zealand
$2.66M +$2.31M +15,437 New
Nisa Investment Advisors
117
Nisa Investment Advisors
Missouri
$2.59M +$2.24M +15,020 New
Aviva
118
Aviva
United Kingdom
$2.55M -$118K -787 -5%
MAG
119
Millrace Asset Group
Pennsylvania
$2.52M +$2.19M +14,651 New
CS
120
Candriam SCA
Luxembourg
$2.41M
HSBC Holdings
121
HSBC Holdings
United Kingdom
$2.39M +$597K +3,999 +41%
Comerica Bank
122
Comerica Bank
Texas
$2.35M +$51.5K +345 +2%
Citigroup
123
Citigroup
New York
$2.29M +$120K +803 +6%
Massachusetts Financial Services
124
Massachusetts Financial Services
Massachusetts
$2.25M +$1.95M +13,034 New
COPPSERS
125
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.06M +$170K +1,139 +11%

AMED Hedge Fund Activity: Q1 2022 in Review

328 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2022, worth a combined $5.19B — up 10% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new AMED positions and 56 closed out — a net gain of 8 holders — while 127 added to existing stakes and 91 trimmed.

The largest buyer was Mackenzie Financial, adding an estimated $57.7M. The largest seller was Viking Global Investors, exiting entirely with an estimated $63.3M sold.

  • 328 institutional investors held Amedisys (AMED) as of Q1 2022, up from 324 in Q4 2021.
  • Funds reported $5.19B of Amedisys stock for Q1 2022, up 10% quarter-over-quarter.
  • 64 funds opened new Amedisys positions in Q1 2022 and 56 closed out, a net change of +8 holders.
  • The largest Amedisys buyer in Q1 2022 was Mackenzie Financial, an estimated $57.7M added.
  • The largest Amedisys seller in Q1 2022 was Viking Global Investors, an estimated $63.3M sold.

Based on aggregated 13F filings for Q1 2022.